A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals
Microorganisms · 04.03.2024 · 12 (3) · 516
DOI: 10.3390/microorganisms12030516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 04.03.2024. Verfasst von Da Hee Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 2…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety.
Abstract (Originalsprache)
Gram-negative bacterial endotoxins can cause pathophysiological effects such as high fever when introduced into the bloodstream. Therefore, endotoxin testing is necessary when producing injectable pharmaceuticals. The pharmaceutical industry has widely used Limulus amebocyte lysate (LAL) to certify product quality. However, ethical concerns have been raised and the increasing scarcity of Limulus polyphemus necessitates the development of novel testing techniques. Recombinant factor C (rFC) was developed using genetic engineering techniques. The aim of this study was to investigate the validity of rFC testing and compare it with the LAL method. The specificity, linearity, accuracy, precision, and robustness of the rFC assay were evaluated. After validation, the rFC assay was found to be suitable for endotoxin detection. We compared the accuracy of the rFC and LAL assays using reference standard endotoxin. The rFC assay was as accurate as the LAL assay. We also compared the two assays using biopharmaceuticals. Greater interference occurred in some samples when the rFC assay was used than when the LAL assay was used. However, the rFC assay overcame the interference when the samples were diluted. Overall, we suggest that rFC can be applied to test biopharmaceuticals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biologics Research Division, Pharmaceutical and Medical Device Research Department, National Institute of Food and Drug Safety Evaluation, Cheongju 28159, Republic of Korea.
ORCID-Profile: Da Hee Kang, Song Yeol Yun
Förderung
- National institute of Food and Drug Safety Evaluation
- Ministry of Food and Drug Safety
Zitieren
APA
Kang, D. H., Yun, S. Y., Eum, S., Yoon, K. E., Ryu, S. R., Lee, C., Heo, H. R., & Lee, K. M. (2024). A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals. Microorganisms, 12(3), 516. https://doi.org/10.3390/microorganisms12030516
Vancouver
Kang DH, Yun SY, Eum S, Yoon KE, Ryu SR, Lee C, et al. A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals. Microorganisms. 2024;12(3):516. doi:10.3390/microorganisms12030516
BibTeX
@article{Kang2024,
author = {Kang, Da Hee and Yun, Song Yeol and Eum, SoYoung and Yoon, Kyung Eun and Ryu, Seung-Rel and Lee, Chulhyun and Heo, Hye-Ryeon and Lee, Kwang Moon},
title = {A Study on the Application of Recombinant Factor C (rFC) Assay Using Biopharmaceuticals},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {3},
pages = {516},
doi = {10.3390/microorganisms12030516}
}
EUVIMED